Live from the NIH registry
Studies recruiting near Tulsa right now
Top 25 of 190 recruiting studies, sorted by proximity — each links to its official registry page
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Endometrial Cancer
Phase 2, Phase 3
Interventional 268 participants sought
Oklahoma Cancer Specialists and Research Institute — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Kartos Therapeutics, Inc.
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 144 participants sought
Essential Medical Research- Site Number : 8400015 — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Sanofi
Amplification of Positivity for Alcohol Use
Alcohol Use Disorder, Anxiety
N/A
Interventional 100 participants sought
Laureate Institute for Brain Research — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Laureate Institute for Brain Research, Inc.
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Cervical Cancer
Phase 4
Interventional 100 participants sought
Oklahoma Cancer Specialists and Research Institute, LLC — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Pfizer
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
DelRicht Clinical Research - Tulsa — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Ardelyx
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Obesity or Overweight
Phase 3
Interventional 2,500 participants sought
Research Site — Tulsa, Oklahoma (5.3 mi)
· Sponsor: AstraZeneca
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Schizophrenia
N/A
Observational 1,500 participants sought
Local Institution - 0052 — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Bristol-Myers Squibb
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
Tricuspid Regurgitation
N/A
Interventional 65 participants sought
Oklahoma Heart Institute — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Laplace Interventional, Inc
A Phase 2 Study of NT-101 Topical in Patients With Wet AMD
Wet Age Related Macular Degeneration
Phase 2
Interventional 66 participants sought
Tulsa Retina Consultants — Tulsa, Oklahoma (5.3 mi)
· Sponsor: NexThera Co., Ltd.
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Mitral Annular Calcification, Mitral Stenosis
N/A
Interventional 210 participants sought
Oklahoma Heart Institute Utica Office — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Mayra Guerrero
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Pulmonary Hypertension Due to Lung Diseases and Hypoxia, Pulmonary Hypertension
N/A
Observational 900 participants sought
Oklahoma Heart Institute — Tulsa, Oklahoma (5.3 mi)
· Sponsor: United Therapeutics
Pan-tumor MRD Study
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer
N/A
Observational 1,350 participants sought
Oklahoma Cancer Specialists and Research Institute (OCSRI) — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Paradigm Health
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
Psoriatic Arthritis, Overweight or Obesity
Phase 4
Interventional 200 participants sought
Essential Medical Research — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Eli Lilly and Company
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
Coronary Artery Disease, High Risk Percutaneous Coronary Intervention
N/A
Interventional 358 participants sought
Oklahoma Heart Hillcrest Medical — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Supira Medical
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Tulsa Retina Consultants — Tulsa, Oklahoma (5.3 mi)
· Sponsor: EyeBiotech Ltd.
Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy
Breast Cancer, Lymphoma
EARLY/Phase 1
Interventional 104 participants sought
Stephenson Cancer Center- Tulsa — Tulsa, Oklahoma (5.3 mi)
· Sponsor: University of Oklahoma
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Parkinson Disease, Parkinson
Phase 2
Interventional 150 participants sought
The Movement Disorder Clinic of Oklahoma — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Neuron23 Inc.
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Axsome Therapeutics, Inc.
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Lewy Body Dementia Psychosis
Phase 2
Interventional 180 participants sought
The Movement Disorder Clinic of Oklahoma — Tulsa, Oklahoma (5.3 mi)
· Sponsor: ACADIA Pharmaceuticals Inc.
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
DelRicht Research - Tulsa — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Crystalys Therapeutics
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Phase 2, Phase 3
Interventional 992 participants sought
Oklahoma Cancer Specialists and Research Institute-Tulsa — Tulsa, Oklahoma (5.3 mi)
· Sponsor: National Cancer Institute (NCI)
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Asthma
Phase 3
Interventional 724 participants sought
Teva Investigational Site 12155 — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Teva Branded Pharmaceutical Products R&D LLC
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
Moderate Aortic Valve Stenosis
Phase 2, Phase 3
Interventional 1,276 participants sought
Ascension St. John Hospital — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Kardigan, Inc.
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma
Phase 3
Interventional 336 participants sought
Oklahoma Cancer Specialists and Research Institute-Tulsa — Tulsa, Oklahoma (5.3 mi)
· Sponsor: National Cancer Institute (NCI)
Dose-Dependent Effects of Low-Intensity Focused Ultrasound
Healthy Controls
N/A
Interventional 66 participants sought
Laureate Institute for Brain Research — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Laureate Institute for Brain Research, Inc.